Abstract:Pancreatic cancer is a devastating disease with a high mortality rate and a lack of effective therapies. The challenges associated with early detection and the highly aggressive nature of pancreatic cancer have limited treatment options, underscoring the urgent need for better disease-modifying therapies. Peptide-based biotherapeutics have become an attractive area of research due to their favorable properties such as high selectivity and affinity, chemical modifiability, good tissue permeability, and easy metabolism and excretion. Phage display, a powerful technique for identifying peptides with high affinity and specificity for their target molecules, has emerged as a key tool in the discovery of peptide-based drugs. Phage display technology involves the use of bacteriophages to express peptide libraries, which are then screened against a target of interest to identify peptides with desired properties. This approach has shown great promise in cancer diagnosis and treatment, with potential applications in targeting cancer cells and developing new therapies. In this comprehensive review, we provide an overview of the basic biology of phage vectors, the principles of phage library construction, and various methods for binding affinity assessment. We then describe the applications of phage display in pancreatic cancer therapy, targeted drug delivery, and early detection. Despite its promising potential, there are still challenges to be addressed, such as optimizing the selection process and improving the pharmacokinetic properties of phage-based drugs. Nevertheless, phage display represents a promising approach for the development of novel targeted therapies in pancreatic cancer and other tumors. Graphical abstract

Phage display screening of therapeutic peptide for cancer targeting and therapy

Selectively Suppressing Tumor Angiogenesis for Targeted Breast Cancer Therapy by Genetically Engineered Phage.

Generation of peptides using phage display technology for cancer diagnosis and molecular imaging

Phage Display-Based Nanotechnology Applications in Cancer Immunotherapy

Guiding nanomaterials to tumors for breast cancer precision medicine: from tumor-targeting small-molecule discovery to targeted nanodrug delivery.

Phage display for discovery of anticancer antibodies

Phage-based peptides for pancreatic cancer diagnosis and treatment: alternative approach

Phage Display as a Medium for Target Therapy Based Drug Discovery, Review and Update

Tumor-Targeting Peptides Search Strategy for the Delivery of Therapeutic and Diagnostic Molecules to Tumor Cells

Peptide Phage Display as a Tool for Drug Discovery: Targeting Membrane Receptors

The role of phage display in therapeutic antibody discovery

Progress on Phage Display Technology: Tailoring Antibodies for Cancer Immunotherapy

PHASTpep: Analysis Software for Discovery of Cell-Selective Peptides via Phage Display and Next-Generation Sequencing

Modification of phage display technique for improved screening of high-affinity binding peptides

Phage display technology and its impact in the discovery of novel protein-based drugs

Exploiting Phage Display for Development of Novel Cellular Targeting Strategies

Phage display enables machine learning discovery of cancer antigen specific TCRs

Design of Cell-Specific Targeting Peptides for Cancer Therapy

Targeting of peptide‐binding receptors on cancer cells with peptide‐drug conjugates

Improving Pharmacokinetics of Peptides Using Phage Display

Recent Progress in Phage‐Based Nanoplatforms for Tumor Therapy